HB 1611 creates a new statutory rebuttable presumption in criminal cases involving second-degree murder or manslaughter when a forensic toxicology report shows that a Schedule I controlled substance was present in the alleged victim at the time of death. Under the bill, the defense would benefit from a presumption that the death was the result of the controlled substance, rather than the defendant’s conduct, in those specified cases. The presumption is rebuttable, so prosecutors could still present evidence to overcome it.
The bill is narrowly targeted and would take effect July 1, 2025. It adds a new section to the Florida Statutes, s. 782.073, and would affect homicide prosecutions where toxicology evidence shows the presence of a Schedule I drug. In practice, it could influence charging, trial strategy, and causation arguments in cases where drug use is alleged to have contributed to or caused the death.
Impact
HB 1611 would amend Florida’s criminal homicide framework by creating a defense-oriented evidentiary presumption in certain death cases. It would not change the elements of second-degree murder or manslaughter directly, but it would alter how causation may be argued when the decedent had a Schedule I controlled substance in their system. The bill would primarily affect prosecutors, criminal defendants, forensic experts, and courts handling homicide cases involving toxicology evidence.
Sentiment
No committee transcripts or recorded votes were provided, so there is no documented debate or formal vote history to gauge legislative sentiment. Based on the bill text alone, the measure appears to be framed as a criminal-defense protection focused on causation disputes in overdose- or drug-involved death cases. The caption and structure suggest a policy interest in limiting criminal liability where controlled substances may have been the primary cause of death.
Contention
The main point of contention is likely to be whether the presence of a Schedule I controlled substance should create a presumption favoring the defense, especially in serious homicide prosecutions. Supporters would likely argue that toxicology evidence can show the death was caused by the victim’s own drug use rather than the defendant’s conduct, while opponents may argue the presumption could make it harder to prosecute cases where a defendant’s actions contributed to the death. Another likely issue is the bill’s narrow focus on Schedule I substances and whether that scope is too broad or too limited for real-world cases.